Evidence map›Paper›PMID 31333679›Full record

ArticleFrontiers in immunology2019

Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses.

Alba Grifoni, Eugene Moore, Hannah Voic, John Sidney, Elizabeth Phillips, Ramesh Jadi, Simon Mallal, Aruna D De Silva, Aravinda M De Silva, Bjoern Peters and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. CD4+ T Cell Epitope Identification from Complex Parasite Antigen Mixtures.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  11. Article
  12. Article
  13. Cancers · 2021
    Article
  14. Article
  15. Article
  16. Comprehensive Analysis of CD4Frontiers in immunology · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Alba GrifoniDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, United States.
Eugene MooreDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, United States.
Hannah VoicDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, United States.
John SidneyDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, United States.
Elizabeth PhillipsInstitute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia.
Ramesh JadiDepartment of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, United States.
Simon MallalInstitute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia.
Aruna D De SilvaDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, United States.
Aravinda M De SilvaDepartment of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, United States.
Bjoern PetersDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, United States.
Daniela WeiskopfDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, United States.
Alessandro SetteDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, United States.
La Jolla Institute for Immunology · USMurdoch University · AUGenetech (Sri Lanka) · LKUniversity of North Carolina at Chapel Hill · US

Funding

NIAID NIH HHS HHSN272200900042C
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllelesAntibody SpecificityCD4-Positive T-LymphocytesDengueDengue VirusEpitopes, T-LymphocyteHLA-DP AntigensHLA-DRB1 ChainsHumansInterferon-gammaEpitopes, T-LymphocyteHLA-DP AntigensHLA-DRB1 ChainsInterferon-gammaadaptive immunityCD4+T cellsDENVHLA-DPHLA-DQHLA-DRB3/4/5

Identifiers

PMID31333679
PMCPMC6624677
OpenAlexW2955811377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.